Kidney Week

Clinical Practice Session

Therapeutic Decisions in Glomerular Diseases: Updating the Algorithms

October 25, 2024 | 10:30 AM - 12:30 PM

Location: Room 6A, Convention Center

Session Description

Therapeutic decision-making in glomerular diseases is often based on less-than-adequate data and comes with high costs and risk of adverse effects. This session reviews these challenging therapeutic decisions and provides insights from experts.

Support is provided by an educational grant from Travere Therapeutics, Inc.

Learning Objective(s)

• Summarize current evidence for use of avacopan, plasmapheresis, and rituximab in ANCA-associated vasculitis
• Describe the current therapeutic options for maintenance therapy in lupus nephritis
• Explain appropriate use of endothelin receptor antagonists, targeted-release formulation budesonide, and SGLT2 inhibitors in the management of IgAN
• Discuss alternatives to corticosteroids and their application in management of minimal change disease

Learning Pathway(s)

• Glomerular Diseases

Moderators

• Annette Bruchfeld, MD, PhD
• Ali Mehdi, MD, MEd, FASN

Presentations

• Management of Acute ANCA-Associated Glomerulonephritis: Evidence and Uncertainties
  10:30 AM - 11:00 AM
  
  • Duvuru Geetha, MD, FASN

Management of Acute ANCA-Associated Glomerulonephritis: Evidence and Uncertainties

October 25, 2024 | 10:30 AM - 11:00 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Approach to Maintenance Therapy in Lupus Nephritis
  11:00 AM - 11:30 AM
  
  • Samir V. Parikh, MD, FASN

Approach to Maintenance Therapy in Lupus Nephritis

October 25, 2024 | 11:00 AM - 11:30 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Use of SGLT2 Inhibitors, Endothelin Receptor Antagonists, and Targeted-Release Formulation Budesonide in IgAN
  11:30 AM - 12:00 PM
  
  • Pietro A. Canetta, MD, MS

Use of SGLT2 Inhibitors, Endothelin Receptor Antagonists, and Targeted-Release Formulation Budesonide in IgAN

October 25, 2024 | 11:30 AM - 12:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Treatment of Minimal Change Disease: Beyond Corticosteroids
  12:00 PM - 12:30 PM
  
  • Ladan Zand, MD

Treatment of Minimal Change Disease: Beyond Corticosteroids

October 25, 2024 | 12:00 PM - 12:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.